Loading...
Novel ALK inhibitors in clinical use and development
Anaplastic lymphoma kinase 1 (ALK-1) is a member of the insulin receptor tyrosine kinase family. ALK-1 was initially found in anaplastic large cell lymphoma (ALCL). ALK mutations have also been implicated in the pathogenesis of non-small cell lung cancer (NSCLC) and other solid tumors. Multiple smal...
Saved in:
| Published in: | J Hematol Oncol |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
BioMed Central
2015
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4349797/ https://ncbi.nlm.nih.gov/pubmed/25888090 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-015-0122-8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|